---
figid: PMC4082763__nihms-553401-f0001
figtitle: 'Protein Prenylation and Synaptic Plasticity: Implications for Alzheimer’s
  Disease'
organisms:
- NA
organisms_ner:
- Drosophila melanogaster
- Homo sapiens
pmcid: PMC4082763
filename: nihms-553401-f0001.jpg
figlink: /pmc/articles/PMC4082763/figure/F1/
number: F1
caption: HMG-CoA reductase is a rate-limiting enzyme in the mevalonate pathway. Statins
  inhibit the activity of HMG-CoA reductase and limit the production of isoprenoid
  intermediates and cholesterol. Farnesyl pyrophosphate (FPP) and geranylgeranyl pyrophosphate
  (GGPP) serve as lipid donors for protein prenylation. Farnesyl transferase inhibitors
  (FTIs) and geranylgeranyl transferase-1 inhibitors (GGTIs) block protein farnesylation
  and geranylgeranylation, respectively (see text for details). PP, pyrophosphate;
  FPPS, farnesyl PP synthase; GGPPS, geranylgeranyl PP synthase; SS, squalene synthase;
  FT, farnesyl transferase; GGT-1, geranylgeranyl transferase-1; GGT-2, geranylgeranyl
  transferase-2 (a.k.a., RabGGT).
papertitle: 'Protein Prenylation and Synaptic Plasticity: Implications for Alzheimer’s
  Disease.'
reftext: David A. Hottman, et al. Mol Neurobiol. ;50(1):177-185.
year: ''
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9119754
figid_alias: PMC4082763__F1
figtype: Figure
redirect_from: /figures/PMC4082763__F1
ndex: 5747bc0e-df09-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC4082763__nihms-553401-f0001.html
  '@type': Dataset
  description: HMG-CoA reductase is a rate-limiting enzyme in the mevalonate pathway.
    Statins inhibit the activity of HMG-CoA reductase and limit the production of
    isoprenoid intermediates and cholesterol. Farnesyl pyrophosphate (FPP) and geranylgeranyl
    pyrophosphate (GGPP) serve as lipid donors for protein prenylation. Farnesyl transferase
    inhibitors (FTIs) and geranylgeranyl transferase-1 inhibitors (GGTIs) block protein
    farnesylation and geranylgeranylation, respectively (see text for details). PP,
    pyrophosphate; FPPS, farnesyl PP synthase; GGPPS, geranylgeranyl PP synthase;
    SS, squalene synthase; FT, farnesyl transferase; GGT-1, geranylgeranyl transferase-1;
    GGT-2, geranylgeranyl transferase-2 (a.k.a., RabGGT).
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - Coa
  - Ipp
  - CG9784
  - CG9426
  - CG6805
  - Synj
  - INPP5E
  - 5PtaseI
  - opm
  - gpp
  - Fpps
  - ras
  - Ras64B
  - Ras85D
  - ft
  - qm
  - rho
  - Bx
  - Rho1
  - Lcp65Ab1
  - Rac1
  - Rac2
  - Akt
  - Mtl
  - Ggt-1
  - betaggt-I
  - ss
  - rab
  - Rab5
  - IPP
  - OFCC1
  - FDPS
  - KRAS
  - HRAS
  - NRAS
  - MSX2
  - GGPS1
  - RHO
  - RHOD
  - RHOA
  - RHOB
  - RHOC
  - AKT1
  - RAC1
  - RAC2
  - RAC3
  - RHOG
  - GGT1
  - AGFG1
  - RAB10
  - RAB11A
  - RAB11B
  - RAB12
  - RAB13
  - RAB14
  - RAB15
  - RAB17
  - RAB18
  - RAB19
  - RAB1A
  - RAB1B
  - RAB1C
  - RAB20
  - RAB21
  - RAB22A
  - RAB23
  - RAB24
  - RAB25
  - RAB26
  - RAB27A
  - RAB27B
  - RAB28
  - RAB2A
  - RAB2B
  - RAB30
  - RAB31
  - RAB32
  - RAB33A
  - RAB33B
  - RAB34
  - RAB35
  - RAB36
  - RAB37
  - RAB38
  - RAB39A
  - RAB39B
  - RAB3A
  - RAB3B
  - RAB3C
  - RAB3D
  - RAB40A
  - RAB40AL
  - RAB40B
  - RAB40C
  - RAB41
  - RAB42
  - RAB43
  - RAB44
  - RAB4A
  - RAB4B
  - RAB5A
  - RAB5B
  - RAB5C
  - RAB6A
  - RAB6B
  - RAB6C
  - RAB7A
  - RAB7B
  - RAB29
  - RAB8A
  - RAB8B
  - RAB9A
  - RAB9B
  - RABL2A
  - RABL2B
  - RABL3
  - IFT22
  - GGT2P
  - 3-Hydroxy-3-methylglutaryl CoA
  - Cholesterol
  - Mevalonate
  - Squalene
---
